Nancy Yuen

732 total citations
9 papers, 534 citations indexed

About

Nancy Yuen is a scholar working on Toxicology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Nancy Yuen has authored 9 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Toxicology, 3 papers in Pharmacology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Nancy Yuen's work include Pharmacovigilance and Adverse Drug Reactions (5 papers), Statistical Methods in Clinical Trials (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Nancy Yuen is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (5 papers), Statistical Methods in Clinical Trials (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Nancy Yuen collaborates with scholars based in United States, United Kingdom and Spain. Nancy Yuen's co-authors include June S. Almenoff, William DuMouchel, Edward N. Pattishall, Stephen Evans, Christine M. Hunt, John Walsh, Ayako Suzuki, Vaishali Patadia, Susan T. Sacks and Louisa Walsh and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Drug Discovery Today and Clinical Gastroenterology and Hepatology.

In The Last Decade

Nancy Yuen

9 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Yuen United States 7 287 133 104 102 83 9 534
Ola Caster Sweden 14 451 1.6× 75 0.6× 141 1.4× 159 1.6× 103 1.2× 26 832
Charles M. Gerrits United States 14 337 1.2× 53 0.4× 124 1.2× 130 1.3× 168 2.0× 19 1.0k
Stella G. Machado United States 10 340 1.2× 67 0.5× 147 1.4× 182 1.8× 149 1.8× 17 969
C. Kreft-Jaïs France 14 249 0.9× 70 0.5× 166 1.6× 59 0.6× 40 0.5× 38 774
Vaishali Patadia United States 9 347 1.2× 53 0.4× 92 0.9× 116 1.1× 91 1.1× 13 525
Johan Hopstadius Sweden 7 284 1.0× 29 0.2× 86 0.8× 116 1.1× 98 1.2× 8 506
Gianmario Candore Netherlands 9 326 1.1× 50 0.4× 106 1.0× 100 1.0× 56 0.7× 18 515
Johanna Strandell Sweden 9 249 0.9× 96 0.7× 80 0.8× 58 0.6× 24 0.3× 15 489
Alexandra Păcurariu Netherlands 12 184 0.6× 58 0.4× 105 1.0× 37 0.4× 38 0.5× 24 524
Joseph M. Tonning United States 9 196 0.7× 40 0.3× 75 0.7× 98 1.0× 48 0.6× 13 503

Countries citing papers authored by Nancy Yuen

Since Specialization
Citations

This map shows the geographic impact of Nancy Yuen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Yuen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Yuen more than expected).

Fields of papers citing papers by Nancy Yuen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Yuen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Yuen. The network helps show where Nancy Yuen may publish in the future.

Co-authorship network of co-authors of Nancy Yuen

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Yuen. A scholar is included among the top collaborators of Nancy Yuen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Yuen. Nancy Yuen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Chen, Minjun, et al.. (2018). Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury. Regulatory Toxicology and Pharmacology. 94. 101–107. 30 indexed citations
2.
DuMouchel, William, et al.. (2013). Automated Method for Detecting Increases in Frequency of Spontaneous Adverse Event Reports over Time. Journal of Biopharmaceutical Statistics. 23(1). 161–177. 5 indexed citations
3.
Vanderwall, Dana E., Nancy Yuen, James M. Bailey, et al.. (2011). Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery – the GSK experience. Drug Discovery Today. 16(15-16). 646–653. 8 indexed citations
4.
Yuen, Nancy, et al.. (2011). Spontaneous adverse event reports of Stevens–Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications. Pharmacoepidemiology and Drug Safety. 21(3). 289–296. 25 indexed citations
5.
Yuen, Nancy, et al.. (2009). Drug-induced liver injury following positive drug rechallenge. Regulatory Toxicology and Pharmacology. 54(1). 84–90. 61 indexed citations
6.
Suzuki, Ayako, et al.. (2009). Co-medications That Modulate Liver Injury and Repair Influence Clinical Outcome of Acetaminophen-Associated Liver Injury. Clinical Gastroenterology and Hepatology. 7(8). 882–888. 29 indexed citations
7.
Almenoff, June S., et al.. (2007). Novel Statistical Tools for Monitoring the Safety of Marketed Drugs. Clinical Pharmacology & Therapeutics. 82(2). 157–166. 197 indexed citations
8.
Almenoff, June S., Gregory Powell, David Fram, et al.. (2007). Online Signal Management: A Systems-Based Approach That Delivers New Analytical Capabilities and Operational Efficiency to the Practice of Pharmacovigilance. Drug Information Journal. 41(6). 779–789. 6 indexed citations
9.
Almenoff, June S., Joseph M. Tonning, A. Lawrence Gould, et al.. (2005). Perspectives on the Use of Data Mining in Pharmacovigilance. Drug Safety. 28(11). 981–1007. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026